Mammographic density and breast cancer risk: The role of the fat surrounding the fibroglandular tissue

Breast Cancer Research

Volumn 13, Issue 5, 2011, Pages

  Lokate, Mariëtte ^a   Peeters, Petra H M ^a,c   Peelen, Linda M ^a   Haars, Gerco ^b   Veldhuis, Wouter B ^a   van Gils, Carla H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Julius Clinical Research   (Netherlands)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; DENSITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOPHYSIOLOGY; POSTMENOPAUSE; RISK FACTOR; AGED; BREAST TUMOR; CASE CONTROL STUDY; COHORT ANALYSIS; EVALUATION; MAMMARY GLAND; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; STATISTICAL MODEL;

ADIPOSE TISSUE; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS;

EID: 84055188730     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3044     Document Type: Article

References (41)

1. Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 2007, 9:217. 10.1186/bcr1829, 2246184, 18190724.
2. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1159-1169. 10.1158/1055-9965.EPI-06-0034, 16775176.
3. Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH. Greatly Increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res 2005, 7:R605-R608. 10.1186/bcr1260, 1242126, 16168104.
4. Haars G, van Noord PA, van Gils CH, Grobbee DE, Peeters PH. Measurements of breast density: no ratio for a ratio. Cancer Epidemiol Biomarkers Prev 2005, 14:2634-2640. 10.1158/1055-9965.EPI-05-0824, 16284389.
5. Maskarinec G, Meng L. A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat 2000, 63:153-161. 10.1023/A:1006486319848, 11097091.
6. Nagata C, Matsubara T, Fujita H, Nagao Y, Shibuya C, Kashiki Y, Shimizu H. Mammographic density and the risk of breast cancer in Japanese women. Br J Cancer 2005, 92:2102-2106. 10.1038/sj.bjc.6602643, 2361821, 15956963.
7. Stone J, Warren RM, Pinney E, Warwick J, Cuzick J. Determinants of percentage and area measures of mammographic density. Am J Epidemiol 2009, 170:1571-1578. 10.1093/aje/kwp313, 19910376.
8. Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG. A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control 1995, 6:431-438. 10.1007/BF00052183, 8547541.
9. Ursin G, Longnecker MP, Haile RW, Greenland S. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995, 6:137-141. 10.1097/00001648-199503000-00009, 7742399.
10. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995, 87:1622-1629. 10.1093/jnci/87.21.1622, 7563205.
11. Wong CS, Lim GH, Gao F, Jakes RW, Offman J, Chia KS, Duffy SW. Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer 2011, 104:871-874. 10.1038/sj.bjc.6606085, 21245860.
12. Chamras H, Bagga D, Elstner E, Setoodeh K, Koeffler HP, Heber D. Preadipocytes stimulate breast cancer cell growth. Nutr Cancer 1998, 32:59-63. 10.1080/01635589809514719, 9919612.
13. Roth J, Qiang X, Marban SL, Redelt H, Lowell BC. The obesity pandemic: where have we been and where are we going?. Obes Res 2004, 12:88S-101S.
14. Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M, Minkin S. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:2086-2092. 10.1158/1055-9965.EPI-06-0345, 17119032.
15. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003, 12:332-338.
16. Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN. Mammographic density and breast cancer risk: the multiethnic cohort study. Am J Epidemiol 2005, 162:743-752. 10.1093/aje/kwi270, 16150892.
17. Duffy SW, Jakes RW, Ng FC, Gao F. Interaction of dense breast patterns with other breast cancer risk factors in a case-control study. Br J Cancer 2004, 91:233-236. 2409810, 15188001.
18. Stuedal A, Ma H, Bernstein L, Pike MC, Ursin G. Does breast size modify the association between mammographic density and breast cancer risk?. Cancer Epidemiol Biomarkers Prev 2008, 17:621-627. 10.1158/1055-9965.EPI-07-2554, 18349279.
19. Stone J, Ding J, Warren RM, Duffy SW, Hopper JL. Using mammographic density to predict breast cancer risk: dense area or percent dense area. Breast Cancer Res 2010, 12:R97. 10.1186/bcr2778, 3046440, 21087468.
20. Johnston PG, Rondinone CM, Voeller D, Allegra CJ. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line. Cancer Res 1992, 52:6860-6865.
21. Iyengar P, Espina V, Williams TW, Lin Y, Berry D, Jelicks LA, Lee H, Temple K, Graves R, Pollard J, Chopra N, Russell RG, Sasisekharan R, Trock BJ, Lippman M, Calvert VS, Petricoin EF, Liotta L, Dadachova E, Pestell RG, Lisanti MP, Bonaldo P, Scherer PE. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 2005, 115:1163-1176. 1077173, 15841211.
22. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 2003, 22:6408-6423. 10.1038/sj.onc.1206737, 14508521.
23. Rahimi N, Saulnier R, Nakamura T, Park M, Elliott B. Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA Cell Biol 1994, 13:1189-1197. 10.1089/dna.1994.13.1189, 7811385.
24. Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J. Concentration of sex steroids in adipose tissue after menopause. Steroids 1998, 63:319-321. 10.1016/S0039-128X(98)00019-1, 9618794.
25. Thijssen JH. Local biosynthesis and metabolism of oestrogens in the human breast. Maturitas 2004, 49:25-33. 10.1016/j.maturitas.2004.06.004, 15351093.
26. Cleary MP, Grossmann ME. Minireview: obesity and breast cancer: the estrogen connection. Endocrinology 2009, 150:2537-2542. 10.1210/en.2009-0070, 2689796, 19372199.
27. Purohit A, Reed MJ. Regulation of estrogen synthesis in postmenopausal women. Steroids 2002, 67:979-983. 10.1016/S0039-128X(02)00046-6, 12398994.
28. Boker LK, van Noord PA, van der Schouw YT, Koot NV, Bueno de Mesquita HB, Riboli E, Grobbee DE, Peeters PH. Prospect-EPIC Utrecht: study design and characteristics of the cohort population. european prospective investigation into cancer and nutrition. Eur J Epidemiol 2001, 17:1047-1053. 10.1023/A:1020009325797, 12380720.
29. Beulens JW, Monninkhof EM, Verschuren WM, van der Schouw YT, Smit J, Ocke MC, Jansen EH, van Dieren S, Grobbee DE, Peeters PH, Bueno-de-Mesquita HB. Cohort profile: the EPIC-NL study. Int J Epidemiol 2009, 39:1170-1178.
30. Riboli E, Kaaks R. The EPIC Project: rationale and study design. european prospective investigation into cancer and nutrition. Int J Epidemiol 1997, 26:S6-14. 10.1093/ije/26.suppl_1.S6, 9126529.
31. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, Clavel-Chapelon F, Thiebaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-de-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzalez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002, 5:1113-1124. 10.1079/PHN2002394, 12639222.
32. Grobbee DE, Hoes AW. Case-control studies. 2008, 226-269. Sudbury, MA, USA: Jones & Bartlett Publishers.
33. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994, 39:1629-1638. 10.1088/0031-9155/39/10/008, 15551535.
34. Martin LJ, Boyd NF. Mammographic density. potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 2008, 10:201. 10.1186/bcr1831, 2374950, 18226174.
35. Verheus M, Peeters PH, van Noord PA, van der Schouw YT, Grobbee DE, van Gils CH. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res 2007, 9:R53. 10.1186/bcr1758, 2206729, 17692133.
36. Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2007, 99:1178-1187. 10.1093/jnci/djm062, 17652278.
37. Vachon CM, Sasano H, Ghosh K, Brandt KR, Watson DA, Reynolds C, Lingle WL, Goss PE, Li R, Aiyar SE, Scott CG, Pankratz VS, Santen RJ, Ingle JN. Aromatase immunoreactivity is increased in mammographically dense regions of the breast. Breast Cancer Res Treat 2011, 125:243-252. 10.1007/s10549-010-0944-6, 20526739.
38. Cleary MP, Grossmann ME, Ray A. Effect of obesity on breast cancer development. Vet Pathol 2010, 47:202-213. 10.1177/0300985809357753, 20124008.
39. Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, Cleary MP. Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev 2010, 29:641-653. 10.1007/s10555-010-9252-1, 20821253.
40. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005, 6:798-808. 10.1016/S1470-2045(05)70390-9, 16198986.
41. Lokate M, Kallenberg MG, Karssemeijer N, Van den Bosch MA, Peeters PH, van Gils CH. Volumetric breast density from full-field digital mammograms and its association with breast cancer risk factors: a comparison with a threshold method. Cancer Epidemiol Biomarkers Prev 2010, 19:3096-3105. 10.1158/1055-9965.EPI-10-0703, 20921336.